![Thomas Busch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Thomas Busch currently works at RedHot Diagnostics AB, as Chief Executive Officer & Director and HiloProbe AB, as Director from 2018.
Mr. Busch also formerly worked at Nordic Biolabs AB, as Chief Executive Officer.
Postes actifs de Thomas Busch
| Sociétés | Poste | Début |
|---|---|---|
RedHot Diagnostics AB
 RedHot Diagnostics AB BiotechnologyHealth Technology Provides diagnostic product development | Directeur Général | - |
HiloProbe AB
 HiloProbe AB Medical SpecialtiesHealth Technology Develops biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients | Directeur/Membre du Conseil | 01/01/2018 |
Anciens postes connus de Thomas Busch
| Sociétés | Poste | Fin |
|---|---|---|
Nordic Biolabs AB
 Nordic Biolabs AB Medical SpecialtiesHealth Technology Distributes medical equipment and instruments | Directeur Général | 01/06/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nordic Biolabs AB
Nordic Biolabs AB Medical SpecialtiesHealth Technology Distributes medical equipment and instruments | Health Technology |
RedHot Diagnostics AB
RedHot Diagnostics AB BiotechnologyHealth Technology Provides diagnostic product development | Health Technology |
HiloProbe AB
HiloProbe AB Medical SpecialtiesHealth Technology Develops biomarker test for accurate detection and characterization, of cancer cells in lymph nodes of colorectal cancer patients | Health Technology |
